We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Roche's Investigational Immunotherapy Atezolizumab Shrank Tumours in People with Lung Cancer

News   Aug 19, 2015

 
Roche's Investigational Immunotherapy Atezolizumab Shrank Tumours in People with Lung Cancer
 
 
 

RELATED ARTICLES

Injecting Dying Cells to Trigger Tumor Destruction

News

By directly injecting engineered dying cells into tumors, researchers have successfully triggered the immune system to attack the cancerous cells at multiple sites within the body and reduce tumor growth, in mice.

READ MORE

Cancer Control: Researchers Solve the Structure of Important Transport Protein

News

Scientists have published the first structure of a lactate-transporter of the SLC16-family (SfMCT) that may have therapeutic benefit in cancer.

READ MORE

New Genetic Marker for Premenopausal Breast Cancer

News

Researchers have added a new genetic marker (rs1429142) to the breast cancer map, helping to expand the list of genetic mutations clinicians can watch for in cancer screenings. In Caucasian women carrying the genetic variation breast cancer risk was increased, compared to women without the variation. In premenopausal women, breast cancer risk reached as high as 40%.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE